XNYS
CI
Market cap77bUSD
Jul 09, Last price
291.80USD
1D
0.71%
1Q
7.58%
Jan 2017
118.76%
Name
Cigna Group
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cigna Corporation stands as a leading provider of insurance and related health services, primarily serving the United States market. Its Evernorth division is responsible for a suite of integrated and specialized health services. These offerings span pharmacy management, benefits administration, direct patient care and coordination, and sophisticated intelligence solutions, with clientele including various health plans, employers, government entities, and healthcare providers. The Cigna Healthcare segment, conversely, delivers a wide array of health and well-being products. These encompass medical, pharmacy, behavioral health, dental, and vision plans, coupled with health advocacy initiatives, for both insured and self-insured clientele. Additionally, it offers Medicare Advantage, Medicare Supplement, and Part D plans for older adults, as well as individual health coverage through public and private exchanges. Globally, this segment provides healthcare coverage in international territories and benefits for expatriate employees and staff of multi-national enterprises. Cigna also provides permanent insurance contracts to corporations, serving as a financial vehicle to cover the lives of certain employees in relation to future employer-paid benefit obligations. Its products and services reach customers through a multi-faceted distribution network, including independent insurance brokers and consultants, direct sales to employers, unions, other groups, and individuals, and via public and private health insurance marketplaces. The company, established in 1792, has its main office in Bloomfield, Connecticut.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||